Tag: FDA

FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis ...

Clearmind aims to initiate clinical trials with CMND-100 by year’s end Vancouver, May 13, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or ...

SpineX’s Proprietary non-surgical Device SCiP Offers New Hope for children with Cerebral Palsy LOS ANGELES, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SpineX, Inc., an early stage medtech company today ...

Orphalan announces FDA approval of Cuvrior™ for the treatment of adult patients with stable Wilson’s disease who are de-coppered and tolerant to penicillamine Paris, France 2 May 2022 – Orphalan ...

First novel, nonstimulant option for adults with ADHD in 20 yearsADHD affects an estimated 10 million adults in the U.S. ROCKVILLE, Md., April 29, 2022 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, ...

AUSTIN, Texas, April 21, 2022 /PRNewswire/ -- Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company ...

The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise.  JENA, Germany and DUBLIN, Ireland, April 20, 2022 /PRNewswire/ -- Today, ZEISS ...

 Phase Ib dose-escalating OVATION I Study with GEN-1 in advanced ovarian cancer patients was well received at 2022 AACR Annual Meeting LAWRENCEVILLE, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Celsion ...

SHENZHEN, China, April 15, 2022 /PRNewswire/ -- On April 15th, SonoScape today announced that the U.S. Food and Drug Administration (FDA) has approved its flagship video endoscopy system HD-550 for ...

AUSTIN, Texas, April 13, 2022 /PRNewswire/ -- Direct Biologics, an innovative biotechnology company with a groundbreaking extracellular vesicle (EV) platform drug technology, announced that the U.S. Food and Drug Administration ...